Our office is currently working on various clinical studies. If you are interested in participating on any of the studies below please feel free to contact our research coordinator Suzette Zamora at 954-602-9723 Ext. 312 or click on the link below.

MORPHOTEK- A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Subjects With Low CA125 Platinum-Sensitive Ovarian Cancer

OVA 1 Post Marketing study: Patients over the age of 18 who have been diagnosed with an ovarian cyst. To participate the patient must be scheduled for surgery. Compensation for participation may be available.Uterine


All of our clinical studies are able to be found in clinicaltrials. gov if you have any further questions or want more details regarding the study inclusion/exclusion criteria.